Bioventus Stock Forecast

Stock Price Forecast

The 4 analysts that cover Bioventus stock have a consensus rating of "Strong Buy" and an average price target of $15, which forecasts a 121.57% increase in the stock price over the next year. The lowest target is $13 and the highest is $17.

Price Target: $15 (+121.57%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$15	$15	$17
Change	+92.02%	+121.57%	+121.57%	+151.11%

* Price targets were last updated on Mar 17, 2025.

Analyst Ratings

The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	3	3	3	3
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Caitlin Cronin Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $15	Strong Buy	Maintains	$15	+121.57%	Mar 17, 2025
Robbie Marcus JP Morgan	JP Morgan	Sell → Hold Upgrades $12 → $13	Sell → Hold	Upgrades	$12 → $13	+92.02%	Dec 17, 2024
William Plovanic Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $12 → $15	Strong Buy	Maintains	$12 → $15	+121.57%	Nov 6, 2024
Alexander Nowak Craig-Hallum	Craig-Hallum	Strong Buy Maintains $12 → $17	Strong Buy	Maintains	$12 → $17	+151.11%	Sep 27, 2024
William Plovanic Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $8 → $12	Strong Buy	Maintains	$8 → $12	+77.25%	Aug 13, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

570.85M

from 573.28M

-0.42%

from 573.28M

Revenue Next Year

605.73M

from 570.85M

6.11%

from 570.85M

EPS This Year

0.71

from -0.52

EPS Next Year

0.90

from 0.71

25.47%

from 0.71

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	321.16M	430.90M	512.12M	512.35M	573.28M	570.85M	605.73M	632.26M
Revenue Growth	-5.58%	34.17%	18.85%	0.05%	11.89%	-0.42%	6.11%	4.38%
EPS	3.35	-0.15	-2.59	-2.49	-0.52	0.71	0.90	0.81
EPS Growth	139.54%	-	-	-	-	-	25.47%	-9.77%
Forward PE	-	-	-	-	-	9.49	7.56	8.38
No. Analysts	-	-	-	-	-	4	4	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	594.3M	632.9M	657.3M
Avg	570.9M	605.7M	632.3M
Low	553.4M	584.1M	613.5M

Revenue Growth

Revenue Growth	2025	2026	2027
High	3.7%	10.9%	8.5%
Avg	-0.4%	6.1%	4.4%
Low	-3.5%	2.3%	1.3%

EPS Forecast

EPS	2025	2026	2027
High	0.84	1.05	0.84
Avg	0.71	0.90	0.81
Low	0.65	0.72	0.78

EPS Growth

EPS Growth	2025	2026	2027
High	-	47.1%	-6.2%
Avg	-	25.5%	-9.8%
Low	-	0.2%	-12.5%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.